KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Pfizer (PFE) over the last 16 years, with Q3 2025 value amounting to -$517.0 million.

  • Pfizer's Non Operating Income fell 11275.72% to -$517.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 billion, marking a year-over-year decrease of 3105.29%. This contributed to the annual value of -$4.4 billion for FY2024, which is 187657.66% down from last year.
  • Per Pfizer's latest filing, its Non Operating Income stood at -$517.0 million for Q3 2025, which was down 11275.72% from -$739.0 million recorded in Q2 2025.
  • Pfizer's Non Operating Income's 5-year high stood at $1.7 billion during Q4 2021, with a 5-year trough of -$1.1 billion in Q2 2024.
  • Over the past 5 years, Pfizer's median Non Operating Income value was -$259.0 million (recorded in 2023), while the average stood at -$92.6 million.
  • In the last 5 years, Pfizer's Non Operating Income skyrocketed by 62842.11% in 2021 and then crashed by 157600.0% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Non Operating Income stood at $1.7 billion in 2021, then tumbled by 96.52% to $59.0 million in 2022, then soared by 169.49% to $159.0 million in 2023, then crashed by 252.83% to -$243.0 million in 2024, then crashed by 112.76% to -$517.0 million in 2025.
  • Its last three reported values are -$517.0 million in Q3 2025, -$739.0 million for Q2 2025, and -$953.0 million during Q1 2025.